ArticleThoracic cancer2025

Comparison of the Immune Checkpoint InhibitorFree Survival Between Patients Who Completed and Those Who Discontinued ICI for Non-Small Cell Lung Cancer.

Takahiro Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.